Represented a university medical center in its acquisition of 6 physician practices.
Represented a private investment firm in a healthcare regulatory diligence for their purchase of NovaMed Inc.
Represented a private investment firm focused on the lower middle market, in its leveraged buyout of a designer, manufacturer and seller of equipment and scientific instruments for plants and laboratories in the industrial, biomedical, hospital, educational and governmental markets.
Represented a private investment firm through its portfolio company, in their recent merger agreement with an operator of ambulatory surgery centers in partnership with physicians . The transaction was valued at approximately $214 million, including the assumption or repayment of approximately $105 million of indebtedness.
Represented private equity investment in infusion pump company and related distributorship
McGuireWoods Advises Revelstoke Capital Partners in Deal With Ohio Orthopaedics Group
August 8, 2019
McGuireWoods’ Fry and Roenius Explain New Medicare Address Requirements for Hospital Outpatient Locations
June 14, 2019
Anna Timmerman, Jon Steinberg Discuss Investment in GI Physician Practices
April 5, 2019
Minority Corporate Counsel Association Honors Raj Natarajan as 2019 Rainmaker
March 15, 2019
A View From the Top: Bill Southwick of QualDerm
July 9, 2019
Diligence and Documentation in Private Equity Healthcare Transactions — Five Key Points
May 23, 2019
HB 1243: Florida Senate Does Not Pass Mandatory Healthcare M&A Reporting
May 17, 2019
Dermatology Investment: Getting Staffing, Compensation, and Physician Benefits Just Right – 5 Key Takeaways
May 16, 2019
Why Private Equity Has Eyes on Vision Care
November 27, 2018